Zinc status affects glucose homeostasis and insulin secretion in patients with thalassemia

Nutrients

Volumn 7, Issue 6, 2015, Pages 4296-4307

  Fung, Ellen B ^a,b   Gildengorin, Ginny ^c   Talwar, Siddhant ^b   Hagar, Leah ^b   Lal, Ashutosh ^a  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c Pediatric Clinical Research Center   (United States)

Author keywords

Diabetes; Glucose intolerance; Thalassemia; Zinc

Indexed keywords

COPPER; FERRITIN; GLUCOSE; GROWTH HORMONE; INSULIN; IRON; ZINC; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE HOMEOSTASIS; HORMONAL THERAPY; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; MALE; MIDDLE AGED; ORAL GLUCOSE TOLERANCE TEST; PANCREAS FUNCTION; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; THALASSEMIA; ZINC DEFICIENCY; BETA-THALASSEMIA; BLOOD; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; INSULIN RESISTANCE; METABOLISM; SECRETION (PROCESS); YOUNG ADULT;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; YOUNG ADULT; ZINC;

EID: 84931274964     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7064296     Document Type: Article

References (29)

1. Martin, A.; Thompson, A.A. Thalassemias. Pediatr. Clin. North. Am. 2013, 60, 1383–1391.
2. Vichinsky, E.P. Changing patterns of thalassemia worldwide. Ann. N.Y. Acad. Sci. 2005, 1054, 18–24.
3. Vichinsky, E.P.; Macklin, E.A.; Waye, J.S.; Lorey, F.; Olivieri, N.F. Changes in the epidemiology of thalassemia in North America: A new Minority disease. Pediatrics 2005, 116, e818–e825.
4. de Assis, R.A.; Ribeiro, A.A.; Kay, F.U.; Rosemberg, L.A.; Nomura, C.H.; Loggetto, S.R.; Araujo, A.S.; Fabron Junior, A.; de Almeida Veríssimo, M.P.; Baldanzi, G.R.; et al. Pancreatic iron stores assessed by magnetic resonance imaging (MRI) in beta thalassemic patients. Eur. J. Radiol. 2012, 81, 1465–1470.
5. Noetzli, L.J.; Coates, T.D.; Wood, J.C. Pancreatic iron loading in chronically transfused sickle cell disease is lower than in thalassaemia major. Br. J. Haematol. 2011, 152, 229–233.
6. Noetzli, L.J.; Mittelman, S.D.; Watanabe, R.M.; Coates, T.D.; Wood, J.C. Pancreatic iron and glucose dysregulation in thalassemia major. Am. J. Hematol. 2012, 87, 155–160.
7. Tsapas, A.; Vlachaki, E.; Christoforidis, A.; Sarigianni, M.; Bekjari, E.; Perifanis, V.; Tsapas, V.; Paletas, K.; Athanassiou-Metaxa, M. Insulin sensitivity assessment with euglycemic insulin clamp in adult beta-thalassaemia major patients. Eur. J. Haematol. 2007, 6, 526–530.
8. Christoforidis, A.; Perifanis, V.; Tsatra, I.; Vlachaki, E.; Athanassiou-Metaxa, M. Evolution of OGTT in patients with beta-thalassaemia major in relation to chelation therapy. Diabetes Res. Clin. Pract. 2007, 76, 6–11.
9. Jansen, J.; Karges, W.; Rink, L. Zinc and Diabetes: Clinical links and molecular mechanisms. J. Nutr. Biochem. 2009, 20, 399–417.
10. Capdor, J.; Foster, M.; Petocz, P.; Samman, S. Zinc and glycemic control: A meta-analysis of randomized placebo controlled supplementation trials in humans. J. Trace Elem. Med. Biol. 2013, 27, 137–142, doi:10.1016/j.jtemb.2012.08.001.
11. Fung, E.B.; King, J.C.; Kwiatkowski, J.L.; Huang, J.; Bachrach, L.K.; Sawyer, A.J.; Zemel, B.S.; Vichinsky, E.P. Zinc Supplementation Improves Bone Density in Young Patients with Thalassemia. Am. J. Clin. Nutr. 2013, 98, 960–971.
12. Deshal, M.H.; Hooghoogh, A.H.; Kebryaeezadeh, A.; Kheirabadi, M.; Kazemi, S.; Nasseh, A.; Shariftabrizi, A.; Pasalar, P. Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients. Med. Sci. Monit. 2007, 13, CR235–CR239.
13. Fung, E.B.; Kawchak, D.A.; Zemel, B.S.; Ohene-Frempong, K.; Stallings, V.A. Plasma zinc is an Insensitive Predictor of Zinc Status: Use of Plasma Zinc in children with sickle cell disease. Nutr. Clin. Pract. 2002, 17, 365–372.
14. Hess, S.Y.; Peerson, J.M.; King, J.C.; Brown, K.H. Use of serum zinc concentration as an indicator of population zinc status. Food Nutr. Bull. 2007, 28, S403–S429.
15. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 11, 3160–3167.
16. Matsuda, M.; DeFronzo, R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22, 1462–1470.
17. Hanson, R.L.; Pratley, R.E.; Bogardus, C.; Venkat Narayan, K.M.; Roumain, J.M.L.; Imperatore, G.; Fagot-Campagna, A.; Pettitt, D.J.; Bennett, P.H.; Knowler, W.C. Evaluation of simple indices of insulin sensitivity and insulin secretion for use in epidemiologic studies. Am. J. Epidemiol. 2000, 151, 190–198.
18. Huber, A.M.; Gershoff, S.N. Effect of zinc deficiency in rats on insulin release from the pancreas. J. Nutr. 1973, 103, 1739–1744.
19. Keller, S.R. Role of the insulin-regulated aminopeptidase IRAP in insulin action and diabetes. Biol. Pharm. Bull. 2004, 27, 761–764.
20. Tang, X.H.; Shay, N.F. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J. Nutr. 2001, 131, 1414–1420.
21. Al-Maroof, R.A.; Al-Sharbatti, S.S. Serum zinc levels in diabetic patients and effect of zinc supplementation on glycemic control of type 2 diabetes. Saudi Med. J. 2006, 27, 344–350.
22. Hashemipour, M.; Kelishadi, R.; Shapouri, J.; Sarrafzadegan, N.; Amini, M.; Tavakoli, N.; Movahedian-Attar, A.; Mirmoghtadaee, P.; Poursafa, P. Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children. Hormones 2009, 8, 279–285.
23. Cunningham, J.J.; Fu, A.; Mearkle, P.L.; Brown, R.G. Hyperzincuria in individuals with insulin-dependent diabetes mellitus: Concurrent zinc status and effect of high dose zinc supplementation. Metabolism 1994, 43, 1558–1562.
24. Al-Rafaie, F.N.; Wonke, B.; Wickens, D.G.; Aydinok, Y.; Fielding, A.; Hoffbrand, A.V. Zinc concentration in patients with iron overload receiving oral iron chelator 1,2 dimethyl-3-hydroxypyrid-4-one or desferrioxamine. J. Clin. Path 1994, 47, 657–660.
25. Failla, M.L.; Kiser, R.A. Altered tissue content and cytosol distribution of trace metals in experimental diabetes. J. Nutr. 1981, 111, 1900–1909.
26. Fung, E.B.; Xu, Y.; Trachtenberg, F.; Olivieri, N.; Kwiatkowski, J.L.; Thompson, A.A.; Neufeld, E.J.; Boudreaux, J.; Quinn, C.; Vichinsky, E.P. Inadequate Dietary Intake in Patients with Thalassemia. J. Acad. Nutr. Dietetics 2012, 112, 980–990.
27. Bonfils, L.; Ellervik, C.; Friedrich, N.; Linneberg, A.; Sandholt, C.H.; Jørgensen, M.E.; Jørgensen, T.; Hansen, T.; Pedersen, O.; Allin, K.H. Fasting serum levels of ferritin are associated with impaired beta cell function and decreased insulin sensitivity: A population based study. Diabetologia 2015, 58, 523–533.
28. Wang, C.H.; Wu, K.H.; Tsai, F.J.; Peng, C.-T.; Tsai, C.-H. Comparison of oral and subcutaneous iron chelation therapies in the prevention of major endocrinopathies in b-thalassemia major patients. Hemoglobin 2006, 30, 257–262.
29. Yuen, K.C.; Chong, L.E.; Riddle, M.C. Influence of glucocorticoids and growth hormone on insulin sensitivity in humans. Diabet. Med. 2013, 30, 651–663.